Encapsulating peritoneal sclerosis - Medical and surgical treatment

Peritoneal Dialysis International

Volumn 29, Issue SUPPL. 2, 2009, Pages

  Lo, Wai Kei ^a   Kawanishi, Hideki ^b  

^a TUNG WAH HOSPITAL   (Hong Kong)

^b TSUCHIYA GENERAL HOSPITAL   (Japan)

Author keywords

Encapsulating peritoneal sclerosis; Enterolysis; Immunosuppressives; Noble plication; Tamoxifen

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TAMOXIFEN; GLUCOCORTICOID;

CONFERENCE PAPER; DISEASE CONTROL; DRUG EFFICACY; ENCAPSULATING PERITONEAL SCLEROSIS; ENCAPSULATING PERITONEAL SCLREOSIS; HEMODIALYSIS; HUMAN; INTESTINE OBSTRUCTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MORTALITY; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONITIS; PRIORITY JOURNAL; RECURRENCE RISK; RISK REDUCTION; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT INDICATION; ABDOMINAL SURGERY; METHODOLOGY; PATHOLOGY; PERITONEUM; RECURRENT DISEASE; REVIEW; SCLEROSIS; TREATMENT OUTCOME;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; RECURRENCE; SCLEROSIS; TREATMENT OUTCOME;

EID: 67449090700     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902902s43     Document Type: Conference Paper

References (25)

1. Kawanishi H, Kawaguchi Y, Fikuri H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004; 44:729-37.
2. Turner MW, Holleman JH, Charlotte NC. Successful therapy of sclerosing peritonitis. Semin Dial 1992; 5:316.
3. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999; 12:395-7.
4. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005; 68: 2381-8.
5. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int 2006; 26:203-6.
6. Thirunavukarasu T, Saxena R, Anijeet H, Pai P, Wong CF. Encapsulating peritoneal sclerosis presenting with recurrent ascites and tamoxifen: case reports and review of the literature. Ren Fail 2007; 29:775-6.
7. Gupta S, Woodrow G. Successful treatment of fulminant encapsulating peritoneal sclerosis following fungal peritonitis with tamoxifen. Clin Nephrol 2007; 68:125-9.
8. Pollock CA. Bloody ascites in a patient after transfer from peritoneal dialysis to hemodialysis. Semin Dial 2003; 16: 406-10.
9. Evrenkaya TR, Atasoyu EM, Unver S, Basekim C, Baloglu H, Tulbek MY. Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004; 19:2423-4.
10. Moustafellos P, Hadjianastassiou V, Roy D, Velzeboer NE, Maniakyn N, Vaidya A, et al. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation. Transplant Proc 2006; 38:2913-14.
11. Mesquita M, Guillaume MP, Dratwa M. First use of tamoxifen in an HIV patient with encapsulating peritoneal sclerosis. Clin Drug Invest 2007; 27:727-9.
12. del Peso G, Bajo MA, Gil F, Aguilera A, Ros S, Costero O, et al. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial 2003; 19:32-5.
13. Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int 2005; 25: 285-94.
14. Lafrance JP, Létourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis 2008; 51:e7-10.
15. Aguilera A, Aroeira LS, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, Bajo MA, et al. Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Int J Artif Organs 2005; 28:164-9.
16. Siaphi S, Bozkurt B, Sezak M, Duman S. The effect of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis model (Abstract). Perit Dial Int 2008; 28(Suppl 1):S6.
17. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S39-47.
18. Noble TB. Plication of small intestine as prophylaxis against adhesions. Am J Surgery 1937; 35:41-4.
19. Kawanishi H, Ide K, Yamashita M, Shimomura M, Moriishi M, Tsuchiya S, et al. Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis. Adv Perit Dial 2008; 24:51-5.
20. Lo WK, Chan KT, Leung AC, Pang SW, Tse CY. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11: 166-72.
21. Dejagere T, Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y. Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient. Am J Kidney Dis 2005; 45:e33-7.
22. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007; 27:619-24.
23. Korte MR, Yo M, Betjes MG, Fieren MW, van Saase JC, Boer WH, et al. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant 2007; 22:2412-14.
24. van Westrhenen R, Aten J, Hajji N, de Boer OJ, Kunne C, de Waart DR, et al. Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat. Blood Purif 2007; 25:466-72.
25. Yamamoto R, Nakayama M, Hasegawa T, Miwako N, Yamamoto H, Yokoyami K, et al. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Adv Perit Dial 2002; 18:131-4.